ALTAN, M. Et Al. 2021. Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.1 , 186-191.

ALTAN, M., HABERAL, H. B., AŞCI, A., GÜDELOĞLU, A., DOĞRUL, A. B., YAZICI, M. S., ... AKDOĞAN, B.(2021). Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.1, 186-191.

ALTAN, MESUT Et Al. "Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors," INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.1, 186-191, 2021

ALTAN, MESUT Et Al. "Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.1, pp.186-191, 2021

ALTAN, M. Et Al. (2021) . "Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.1, pp.186-191.

@article{article, author={MESUT ALTAN Et Al. }, title={Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors}, journal={INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY}, year=2021, pages={186-191} }